Key result
The proposed ban on hydroxyethyl starch solutions is highly debated, with experts disagreeing on the interpretation of existing trial data and the European Medicines Agency's regulatory decisions.
No takes yet. Share an insight, caveat, or question.
The authors argue against the proposed ban on hydroxyethyl starch (HES), highlighting methodological flaws in the trials used to justify the ban and criticizing the EMA's rushed recommendation.
Chappell et al. (2018) conducted a letter in Hypovolaemia. Hydroxyethyl starch (HES) was evaluated. The proposed ban on hydroxyethyl starch solutions is highly debated, with experts disagreeing on the interpretation of existing trial data and the European Medicines Agency's regulatory decisions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: